Topic: Oncology

Billionaire philanthropist Sean Parker explains why he's so bullish on cell therapy as part of his Parker Institute for Cancer Immunotherapy.

CMS announced it will allow states to waive the much-maligned IMD exclusion in Medicaid, plus other healthcare headlines.

HHS’ drug pricing plans are meant to signal to the healthcare industry—and voters—that it's serious on this issue, experts say. 

HHS reduced the reach of its bundled payment models last November; some, it stopped entirely. Now, the agency is ready to create new, additional ones.

HHS' plan to bring down Part B prices has drawn skepticism, including from providers who helped sink a similar proposal from the Obama White House. 

Findings from a new study raised concerns around how cancer patients will be cared for in the future.

The FDA has said that a vaccine for HPV can be used in patients up to age 45, plus more healthcare headlines.

NIH Director Francis Collins says there's still plenty to be done to bring precision medicine to its full potential.

Providers participating in a bundled payment model for cancer care may perform better based on the type of cancer they’re treating.

Overtreatment is a pervasive problem in healthcare. But hospitals don't have to invest much to tackle the issue, a group of experts said in D.C.